A detailed history of Mercer Global Advisors Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 6,770 shares of CTLT stock, worth $405,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,770
Previous 7,120 4.92%
Holding current value
$405,861
Previous $402,000 5.47%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$53.58 - $57.02 $18,753 - $19,957
-350 Reduced 4.92%
6,770 $380,000
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $236,208 - $332,001
-5,550 Reduced 43.8%
7,120 $402,000
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $70,635 - $102,221
-2,195 Reduced 14.77%
12,670 $569,000
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $567,572 - $644,618
-12,841 Reduced 46.35%
14,865 $677,000
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $547,800 - $1.16 Million
-17,194 Reduced 38.29%
27,706 $1.2 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $321,760 - $525,835
7,081 Added 18.72%
44,900 $2.95 Million
Q4 2022

Feb 08, 2023

BUY
$41.39 - $81.0 $1.4 Million - $2.75 Million
33,894 Added 863.54%
37,819 $1.7 Million
Q3 2022

Nov 15, 2022

BUY
$72.36 - $113.1 $118,163 - $184,692
1,633 Added 71.25%
3,925 $284,000
Q2 2022

Aug 10, 2022

SELL
$87.2 - $114.05 $42,204 - $55,200
-484 Reduced 17.44%
2,292 $246,000
Q1 2022

May 10, 2022

SELL
$94.19 - $124.49 $611,010 - $807,566
-6,487 Reduced 70.03%
2,776 $308,000
Q4 2021

Feb 04, 2022

SELL
$119.57 - $139.07 $235,313 - $273,689
-1,968 Reduced 17.52%
9,263 $1.19 Million
Q3 2021

Nov 10, 2021

SELL
$109.17 - $142.35 $637,006 - $830,612
-5,835 Reduced 34.19%
11,231 $1.5 Million
Q2 2021

Aug 10, 2021

BUY
$100.34 - $115.69 $178,906 - $206,275
1,783 Added 11.67%
17,066 $1.85 Million
Q1 2021

May 11, 2021

BUY
$101.51 - $125.27 $1.2 Million - $1.48 Million
11,787 Added 337.16%
15,283 $1.61 Million
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $300,236 - $368,338
3,496 New
3,496 $364,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.